entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.
Company profile
Ticker
TRDA
Exchange
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
CycloPorters, Inc.
SEC CIK
Corporate docs
Subsidiaries
Entrada Securities Corporation ...
IRS number
813983399
TRDA stock data
Latest filings (excl ownership)
8-K
Entrada Therapeutics Announces $100 Million Registered Direct Offering
24 Jun 24
424B5
Prospectus supplement for primary offering
24 Jun 24
8-K
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
24 Jun 24
8-K
Amendments to Articles of Incorporation or Bylaws
13 Jun 24
10-Q
2024 Q1
Quarterly report
7 May 24
8-K
Entrada Therapeutics Reports First Quarter 2024 Financial Results
7 May 24
ARS
2023 FY
Annual report to shareholders
29 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
PRE 14A
Preliminary proxy
19 Apr 24
Latest ownership filings
4
Natarajan Sethuraman
16 Jul 24
4
Dipal Doshi
16 Jul 24
144
Notice of proposed sale of securities
15 Jul 24
144
Notice of proposed sale of securities
12 Jul 24
4
KORY JAMES WENTWORTH
10 Jul 24
144
Notice of proposed sale of securities
8 Jul 24
SC 13D/A
BAKER BROS. ADVISORS LP
26 Jun 24
4
JULIAN BAKER
26 Jun 24
4
KUSH PARMAR
14 Jun 24
4
PETER S KIM
14 Jun 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 72.39 mm | 72.39 mm | 72.39 mm | 72.39 mm | 72.39 mm | 72.39 mm |
Cash burn (monthly) | (no burn) | 13.27 mm | (no burn) | (no burn) | 8.51 mm | 7.43 mm |
Cash used (since last report) | n/a | 51.30 mm | n/a | n/a | 32.89 mm | 28.71 mm |
Cash remaining | n/a | 21.09 mm | n/a | n/a | 39.50 mm | 43.67 mm |
Runway (months of cash) | n/a | 1.6 | n/a | n/a | 4.6 | 5.9 |
Institutional ownership, Q1 2024
30.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 11 |
Closed positions | 1 |
Increased positions | 2 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 3.70 bn |
Total shares | 10.31 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
5AM Ventures V | 3.28 mm | $83.47 mm |
Roche Finance | 2.81 mm | $48.17 mm |
MPM BioVentures 2014 | 2.21 mm | $56.38 mm |
MRL Ventures Fund | 1.74 mm | $29.79 mm |
BK Bank Of New York Mellon | 110.60 k | $1.57 bn |
TD Asset Management | 71.31 k | $1.01 bn |
New York Life Investment Management | 25.91 k | $367.20 mm |
Swiss National Bank | 23.00 k | $325.91 mm |
Allspring Global Investments | 14.76 k | $209.19 mm |
New York State Common Retirement Fund | 8.88 k | $126.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jul 24 | Dipal Doshi | Common Stock | Sell | Dispose S | No | Yes | 17.8108 | 1,600 | 28.50 k | 334,475 |
15 Jul 24 | Natarajan Sethuraman | Common Stock | Sell | Dispose S | No | Yes | 18 | 638 | 11.48 k | 188,814 |
12 Jul 24 | Dipal Doshi | Common Stock | Sell | Dispose S | No | Yes | 18 | 300 | 5.40 k | 336,075 |
12 Jul 24 | Natarajan Sethuraman | Common Stock | Sell | Dispose S | No | Yes | 18 | 600 | 10.80 k | 189,452 |
8 Jul 24 | Kory James Wentworth | Common Stock | Sell | Dispose S | No | Yes | 14.95 | 1,758 | 26.28 k | 81,412 |
25 Jun 24 | Baker Bros. Advisors | Warrants to purchase Common Stock Common Stock | Buy | Acquire P | Yes | No | 14.8499 | 3,081,303 | 45.76 mm | 3,081,303 |
25 Jun 24 | Baker Bros. Advisors | Warrants to purchase Common Stock Common Stock | Buy | Acquire P | Yes | No | 14.8499 | 285,700 | 4.24 mm | 285,700 |
13 Jun 24 | Dipal Doshi | Common Stock | Sell | Dispose S | No | Yes | 16.1736 | 1,000 | 16.17 k | 336,375 |